View Agent
| Agent Info | |
| Agent: | rilotumumab |
| Synonyms: | NA |
| Drug Status For Certain Diseases: | Grade IV malignant glioma;Glioblastoma multiforme(Discontinued inphase 2) |
| Classification: | a fully human, monoclonal antibody that neutralises HGF |
| Target: | Hepatocyte growth factor |
| KEGG Pathway: | Renal cell carcinoma Pathways in cancer Malaria Focal adhesion Cytokine-cytokine receptor interaction Melanoma Proteoglycans in cancer Rap1 signaling pathway PI3K-Akt signaling pathway Ras signaling pathway |
| Wiki Pathway: | Prostate Cancer NRF2 pathway Focal Adhesion Interleukin-7 signaling Signaling of Hepatocyte Growth Factor Receptor Differentiation Pathway Extracellular vesicle-mediated signaling in recipient cells Nuclear Receptors Meta-Pathway |